Taysha Gene Therapies
TSHA
TSHA
65 hedge funds and large institutions have $215M invested in Taysha Gene Therapies in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less capital invested
Capital invested by funds: $362M → $215M (-$146M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
65
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.41M | |
| 2 | +$1.3M | |
| 3 | +$908K | |
| 4 |
Two Sigma Investments
New York
|
+$807K |
| 5 |
Millennium Management
New York
|
+$700K |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$5.97M | |
| 3 | -$2.13M | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$745K |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$700K |